From Anthony Akinbola’s solo debut to live screen printing, here is your curated roadmap Everything you need to know about the 18+ gallery openings, live performances, and must-see installations ...

On the Cape Fear River, rising waters are bringing rising risks. Few people know that better than Ilya Smirnov. Other WRAL Top Stories “It might look like not a whole lot is going on, but actually ...

The launch of the historic Artemis II mission, although the highlight, is not the only big sky event that the month of April will feature. From the glow of the Pink Moon and Mercury to a meteor shower ...

The FIA has released its official decision to cancel the upcoming Formula 1 Grand Prix races scheduled for April 2026. The decision has been made due to the growing hostile environment in the middle ...

The federal budget deficit topped $1 trillion in the first five months of fiscal year 2026, as the U.S. government is on pace to record another massive deficit. The nonpartisan Congressional Budget ...

The miracle of rapid weight loss has always come with fine print. Until recently, it read mostly like a list of digestive complaints -stomachaches, constipation - generally unpleasant but tolerable ...

Nick Blackmer is a librarian, fact-checker, and researcher with more than 20 years of experience in consumer-facing health and wellness content. New research suggests prolonged GLP-1 use may be linked ...

Evidence continues to mount suggesting that GLP-1 drugs may help people cut back on cigarettes, drinking and opioid use. Subscribe to read this story ad-free Get unlimited access to ad-free articles ...

In a recent review, a small group of patients received the injections less frequently but still maintained weight loss and health benefits. By Roni Caryn Rabin The doctor kept hearing the same story ...

The plan originated in November, when discussions began about the possibility of a local sales tax. Within weeks, the nonprofit Wichita Forward introduced a formal one percent sales tax proposal to ...

Generic versions of Novo Nordisk A/S’s Ozempic and Wegovy could be sold for less than $3 a month, a new study showed, underscoring their potential to unlock global access to powerful weight-loss drugs ...